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The species *Dermabacter hominis* was established by Jones and Collins in 1988 to classify coryneform bacteria from healthy human skin on the basis of their biochemical characteristics ([@B1]). Subsequent reports assigned coryneform bacteria of the Centers for Disease Control and Prevention (CDC) group 3 and group 5 to the new species *D. hominis*, indicating the potential clinical significance of this microorganism ([@B2], [@B3]). CDC group 3 and group 5 coryneforms were primarily isolated from human blood cultures and less commonly from other body sites ([@B2], [@B3]). Additional reports documented that *D. hominis* was recovered from a brain biopsy specimen ([@B4]), the peritoneal fluid of a dialysis patient ([@B5]), blood cultures of two bacteremic patients ([@B6]), recurrent cutaneous abscesses ([@B7]), human semen specimens ([@B8]), and cases of fatal septicemia ([@B9]) and chronic osteomyelitis ([@B10]).

A recent study reviews clinical features of *D. hominis* infections and contains data on 14 patients attending a tertiary hospital ([@B11]). *D. hominis* was mostly isolated from blood cultures and peritoneal dialysis catheter exit sites. *In vitro* assays demonstrated that the isolates were susceptible to linezolid, rifampin, and vancomycin, whereas their resistance profile to other antibiotics was variable. With the exception of one isolate, all *D. hominis* strains were resistant to the lipopetide antibiotic daptomycin. Isolate no. 5 presented multiple resistances to antibiotics, including daptomycin ([@B11]). To gain access to the repertoire of antibiotic resistance genes of isolate no. 5, we sequenced the genome of this multidrug-resistant strain that was renamed as *D. hominis* 1368.

*D. hominis* 1368 was isolated from blood cultures of a 29-year-old patient suffering from lymphoma and pyelonephritis ([@B11]). The bacterium was grown in brain-heart infusion broth at 37°C to purify genomic DNA with the Genomic DNA buffer set and the Genomic-tip 500/G system (Qiagen). A DNA sequencing library was constructed on the basis of the Nextera DNA sample preparation kit (Illumina) and was sequenced by the 2×250 nucleotide paired-end approach using the MiSeq reagent kit v2 and the MiSeq desktop sequencer (Illumina). This whole-genome shotgun sequencing resulted in 2,163,261 reads and 504,763,054 detected bases. The reads were preprocessed by quality-trimming in such a way that the last five nucleotides at the 3′ end had a Phred quality value of ≥30 ([@B12]). The quality-trimmed reads were assembled with the GS De Novo Assembler software (version 2.8) to yield 56 contigs.

The current draft genome sequence of *D. hominis* 1368 has a size of 2,507,630 bp. The annotation of this nucleotide sequence was performed with the NCBI Prokaryotic Genome Annotation Pipeline and the GeneMarkS+ software (version 2.3), revealing 2,227 protein-coding genes, 21 pseudogenes, 1 non-coding RNA gene, and 48 tRNA genes. Strain 1368 contains typical corynebacterial antibiotic resistance determinants ([@B11], [@B13]), indicating that horizontal gene transfer between *D. hominis* and corynebacteria of the human skin flora plays an important role in the development of multidrug resistance. The genome sequence of *D. hominis* 1368 therefore helps to further the understanding of the variability of resistances to clinically relevant antimicrobials in this species ([@B14][@B15][@B16]).

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

This whole-genome shotgun project has been deposited in GenBank under the accession no. [JDRS00000000](JDRS00000000). The version described in this genome announcement is the first version, JDRS01000000.1.
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